Dyne Therapeutics wins FDA Priority Review for DMD drug z-rostudirsen, with key catalysts and pipeline upside. Click for more ...

Initiated Himalayas-1 global Phase 3 trial in patients with mCRPC previously treated with abiraterone Entered into a clinical trial collaboration and supply agreement with Bayer to provide ...

With EPS growth for the next five years forecasted at 67.57%, Viridian Therapeutics, Inc. (NASDAQ:VRDN) is among the 12 Best Quality Stocks to Buy and Hold for the Next Decade. On June 30, Wedbush ...

Anktiva shows strong NMIBC results and pipeline upside, but valuation, dilution and cash burn raise risk—read now.

Morgan Stanley reiterates Nvidia and Broadcom as overweight The firm said it's sticking with both stocks. "This remains an unusual memory cycle, as data center strength is the only cause – which means ...

Harm reduction orthodoxy has failed the residents of the DTES, who deserve a path to breaking their addictions ...

For months now, Fine Gaelers have watched with increasing bemusement the dramatics of their coalition partner around the ...

The drug and biotech sector is in a recovery mode, after going through a difficult period between 2022 and 2024, backed by strong quarterly results, surging mergers and acquisitions (M&A) activity and ...

Marketed as a "magic pill" or a "courage pill" in Nazi Germany, Pervitin was an early form of methamphetamine that was widely ...

Sri Lanka hopes to complete several water infrastructure development projects by 2026/2027, at a cost of 17 billion rupees, which will provide safe drinking water to around 300,000 families, Minister ...